World News Today

Oman Approves Covaxin Shots For Travel Without Quarantine

“Pre-arrival RT-PCR take a look at shall be relevant for such passengers,” learn the press launch (File)

Muscat:

The Authorities of the Sultanate of Oman on Wednesday added Indian-made Covaxin to the accepted listing of COVID-19 vaccines for journey to the nation with out quarantine.

“COVAXIN has now been added to the accepted listing of COVID-19 vaccines for journey to Oman with out quarantine. This can facilitate travellers from India vaccinated with COVAXIN,” tweeted the Embassy of India in Muscat.

“All passengers from India who’ve obtained two doses of Covaxin not less than 14 days earlier than the estimated arrival date will now be capable of journey to Oman with out the requirement of quarantine. All different COVID-19 associated necessities/circumstances, equivalent to pre-arrival RT-PCR take a look at shall be relevant for such passengers,” learn the press launch of the Indian Embassy.

This notification will considerably ease journey to Oman for Indian nationals who’ve taken Covaxin. Passengers who’ve taken AstraZeneca/Covishield are already permitted to journey to Oman with out quarantine.

Covaxin, India’s first indigenous COVID-19 vaccine, is developed by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Analysis.

In the meantime, the World Well being Organisation (WHO) has stated that the Technical Advisory Group (TAG) for Emergency Use Itemizing has determined that extra clarifications from the producer are wanted to conduct a ultimate EUL risk-benefit evaluation for world use of the vaccine.

The UN well being physique stated that the TAG expects to reconvene for the ultimate risk-benefit evaluation on November 3.

Bharat Biotech has been submitting information to WHO on a rolling foundation and submitted extra data on the UN well being physique’s request on September 27.

Earlier this month, WHO chief scientist Dr Soumya Swaminathan had stated that the UN well being physique’s technical advisory group will meet on October 26 to think about Emergency Use Itemizing (EUL) for Covaxin.Final week, WHO had stated a vaccine beneficial by it for emergency use should be evaluated totally.

(Aside from the headline, this story has not been edited by NDTV employees and is printed from a syndicated feed.)



Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button